Pancreatic cancer belongs to the most malignant gastrointestinal
cancers and the treatment options are limited. The two bioactive components
of turmeric, curcumin and turmeric oil, are reported to have anticancer
properties against pancreatic cancer as well as a number of other cancer cell
lines. These turmeric products make use of a number of different signaling
pathways in their mechanism of action. The low toxicity of these components
and their ability to enhance the activity of other anti-cancer drugs make them
good candidates for the development of new treatment options for pancreatic
cancer. A brief review of the current state of these compounds in pancreatic
cancer research is presented.
Citation: Jacob JN (2013) Turmeric And Pancreatic Cancer- A Review.
Cancer Stud 1: 102.
Keywords: turmeric, pancreatic cancer, curcumin, turmeric oil, paclitaxel,
gemcitabine
Open Access
Peer Reviewed
ISSN: 2378-6264
Cancer Studies
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
Turmeric And Pancreatic Cancer- A Review
James N Jacob
Corresponding Author: James N Jacob
Received: Oct 07, 2013
Accepted: Oct 25, 2013
Published: Nov 02, 2013
Views: 4
DOI: N/A
Abstract
Jacob JN (2013) Turmeric And Pancreatic Cancer- A Review. Cancer Stud 1: 102.
Copyright:
Copyright: © 2013 Jacob. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credite
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credite
Indexed In
Google Scholar
DOAJ
PubMed
Scopus